Winton Group’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,559
| Closed | -$147K | – | 686 |
|
|
2024
Q3 | $147K | Sell |
54,559
-9,351
| -15% | -$25.2K | 0.01% | 584 |
|
|
2024
Q2 | $182K | Sell |
63,910
-131
| -0.2% | -$373 | 0.01% | 537 |
|
|
2024
Q1 | $272K | Sell |
64,041
-96
| -0.1% | -$407 | 0.02% | 537 |
|
|
2023
Q4 | $343K | Sell |
64,137
-23,628
| -27% | -$126K | 0.03% | 499 |
|
|
2023
Q3 | $377K | Buy |
87,765
+51,316
| +141% | +$221K | 0.03% | 434 |
|
|
2023
Q2 | $200K | Buy |
+36,449
| New | +$200K | 0.02% | 672 |
|
|
2022
Q1 | – | Sell |
-12,216
| Closed | -$86K | – | 1042 |
|
|
2021
Q4 | $86K | Sell |
12,216
-50,441
| -81% | -$355K | 0.01% | 972 |
|
|
2021
Q3 | $437K | Sell |
62,657
-6,763
| -10% | -$47.2K | 0.02% | 927 |
|
|
2021
Q2 | $578K | Sell |
69,420
-618
| -0.9% | -$5.15K | 0.03% | 829 |
|
|
2021
Q1 | $382K | Buy |
70,038
+1,328
| +2% | +$7.24K | 0.02% | 1028 |
|
|
2020
Q4 | $295K | Sell |
68,710
-33,226
| -33% | -$143K | 0.02% | 1052 |
|
|
2020
Q3 | $307K | Sell |
101,936
-29,482
| -22% | -$88.8K | 0.01% | 1243 |
|
|
2020
Q2 | $407K | Buy |
131,418
+87,943
| +202% | +$272K | 0.01% | 1226 |
|
|
2020
Q1 | $96K | Sell |
43,475
-3,959
| -8% | -$8.74K | ﹤0.01% | 1329 |
|
|
2019
Q4 | $145K | Buy |
47,434
+1,054
| +2% | +$3.22K | ﹤0.01% | 1470 |
|
|
2019
Q3 | $143K | Buy |
+46,380
| New | +$143K | ﹤0.01% | 1431 |
|